We are building a robust toolbox with the science, discovery engine and commercialization expertise needed to transform the treatment of serious diseases.

This includes scalable, in-house manufacturing to enable us to control the development and supply of our products.

Our 90,000-square foot facility in Lexington, Massachusetts, allows us to continue to meet the synthesis demands of our growing portfolio, increase control and visibility of our product supply and have greater independence and flexibility in manufacturing multiple products.

Our cGMP manufacturing capabilities include:

  • Oligonucleotide synthesis capacity ranging from high throughput to large-scale GMP production
  • Comparable yield and cost-of-goods to standard stereorandom oligonucleotides
  • Industry standard equipment with no biological processing required
  • GMP manufacturing capacity that can be made available to partners